Generic placeholder image

Current Pharmaceutical Analysis

Author(s): Ramu Ivaturi*, Thuttagunta Manikya Sastry and Satyaveni Sunkara

DOI: 10.2174/1573412914666180914163419

DownloadDownload PDF Flyer Cite As
Development and Validation of Stability Indicating HPLC Method for the Determination of Impurities in the Sterile Mixture of Cefoperazone and Sulbactam

Page: [762 - 775] Pages: 14

  • * (Excluding Mailing and Handling)

Abstract

Background: Cefoperazone Sulbactam injection is a cephalosporin antibiotic with a β- lactamase inhibitor used in the treatment for intra abdominal infections, Urinary track infections, surgical infections, etc. The combination is not official in any of the pharmacopeia for their content and impurities determination.

Introduction: The present study involves the development of a simple, rapid, accurate, sensitive and stability indicating RP-HPLC method for the quantitative estimation of Cefoperazone Sulbactam mixture and its impurities in bulk and pharmaceutical dosage forms.

Methods: 0.005 M Tetrabutyl ammonium hydroxide buffer solution pH adjusted to 6.80 and Acetonitrile combination has been used in a gradient programme with a flow rate of 1.0 ml/min. The retention time of Cefoperazone and Sulbactam were observed at around 8.5 and 19.5 minutes respectively. The UV detection was carried out at a wavelength of 230 nm. The chromatographic separation was achieved using Waters xbridge C18-150*4.6 mm, 3.5 µm HPLC column. The method has been validated according to the current International Council for Harmonization (ICH) guidelines for the method validation parameters such as Specificity, linearity, range, accuracy, precision, robustness and sensitivity.

Results: The validation results indicate that the method is specific, as the known impurities and other impurities formed during the forced degradation studies were not co-eluting with the main components. Moreover, all these impurities were found to be spectrally pure, proving the stability indicating power of the method. The linearity and range of the method is in the range of 0.01-150%, highly accurate (100.2%), precise (<1%) and robust.

Conclusion: The proposed method was accurate and specific for the quantitative analysis of Cefoperazone and Sulbactam and their related impurities in the sterile mixture. Hence the proposed method can be used for the quantification of impurities in routine as well as stability analysis in the development as well as quality control laboratories.

Keywords: Cefoperazone sodium, sulbactam sodium, HPLC, LOD, LOQ, ICH, forced degradation.

Graphical Abstract

[1]
Grug Bank. Available from: http://www.drugbank.ca/drugs/DB01329,DB09324.
[2]
Drug Approval Package: Brand Name (Generic Name) NDA # - FDA Available from: http://www.accessdata.fda.gov/drugsatfda_docs.
[3]
Indian Pharmacopoeia, Volume II, the Indian Pharmacopoeia Commission, Ghaziabad, 6th ed, 1014-1016, 2010.
[4]
British Pharmacopoeia. 6th ed, the Stationary Office, London Medicines and Healthcare Product Regulatory Agency, 451-453 and 950-952,, 2016.
[5]
United States Pharmacopoeia, Asian Edition, the United States Pharmacopoeia Convention, Rockville, USA, 2866-2867 and 5207- 5208, 2013.
[6]
Parra, A.; Garcia, V.J.; Rodenas, V.; Gomez, M.D. First and second derivative spectrophotometric determination of Cefoperazone and Sulbactam in injections. J. Pharm. Biomed. Anal., 1994, 12(5), 653-657.
[7]
Saleh, G.A.; Askal, H.F.; Radwan, M.F.; Omar, M.A. Use of charge-transfer complexation in the spectrophotometric analysis of certain cephalosporins. Talanta, 2001, 54(6), 1205-1215.
[8]
Elazazy, M.S.; Shalaby, A.; Elbolkiny, M.N.; Khalil, H.M. Spectrophotometric determination of cefepime hydrochloride, cefoperazone sodium, ceftazidime pentahydrate, cefuroxime sodium and Etamsylate using ammonium molybdate. Sci. Pharm., 2003, 71, 211-228.
[9]
Jane, J.; Subrahmanyam, E.V.S.; Sathyanarayana, D. Spectrophotometric determination of certain cephalosporins. Asian J. Chem., 2006, 18(1), 721-723.
[10]
Saleh, G.A.; El-Shaboury, S.R.; Mohamed, F.A.; Rageh, A.H. Kinetic spectrophotometric determination of certain cephalosporins using oxidized quercetin reagent. Spectrochim. Acta A, 2009, 73(5), 946-954.
[11]
Senthilraja, M.; Sanjaypai, P.N. Spectrophotometric method for the determination of cefoperazone sodium in pharmaceutical formulations. Indian J. Pharm. Sci., 2006, 68(3), 384-385.
[12]
Ratna, K.K.; Devala, R.G. New spectrophotometric methods for the determination of cefoperazone in pharmaceutical formulations. Int. J. Pharm. Res. Dev., 2010, 2(1), 1-5.
[13]
Rageh, A.H.; El-Shaboury, S.R.; Saleh, G.A.; Mohamed, F.A. Spectophotometric method for determination of certain cephalosporins using 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole(NBD-Cl). Nat. Sci., 2010, 2(8), 828-840.
[14]
Rania, A.S.; Wafaa, S.H.; Magda, Y.E.; Abdalla, S. Use of silver – gelatin complex for the determination of cefoperazone sodium, ceftazidime pentahydrate and cefotaxime sodium in pure and pharmaceutical dosage forms. Chem. Sci. Rev. Let, 2012, 1(1), 10-17.
[15]
Bagheri, A.G.; Yosefi, A.; Rezvani, M.; Roshanzamir, S. Spectrophotometric complexation of cephalosporins with palladium (II) chloride in aqueous and non-aqueous solvents. Spectrochim. Acta A, 2012, 89, 317-321.
[16]
Sayed, R.A.; Hassan, W.S.; El-Mammli, M.Y.; Shalaby, A. Development of simple green spectrophotometric and conductometric methods for determination of cephalosporins in pure, pharmaceutical dosage forms and Human Urine. J. Adv. Chem, 2013, 4(3), 532-547.
[17]
Sayed, R.A.; Hassan, W.S. El- Mammli, M.Y.; Shalaby, A. Spectrophotometric method for the determination of cefotaxime Na and cefoperazone Na in pure and pharmaceutical dosage forms. Am. Chem. Sci J, 2013, 3, 514-525.
[18]
Hoang, V.D.; Loan, N.T.; Tho, V.T.; Nguyen, H.M.T. UV spectrophotometric simultaneous determination of cefoperazone and Sulbactam in pharmaceutical formulations by derivative, Fourier and wavelet transforms. Spectrochimica. Acta A: Mol. Biomol. Spect, 2014, 121, 704-714.
[19]
Patel, K.P.; Maheshwari, D.G. Development and validation of first order derivative UV spectrophotometric method for simultaneous Eetimation of Cefoperazone sodium and Tazobactam sodium in pharmaceutical formulation. Am. J. Pharm. Tech. Res., 2014, 4(3), 499-508.
[20]
Amin, A.S.; Ragab, G.H. Spectrophotometric determination of certain cephalosphorins in pure form and in pharmaceutical formulations. Spectrochimica. Acta A: Mol. Biomol. Spect, 2004, 60(12), 2831-2835.
[21]
Al-Momani, I.F. Spectrophotometric determination of selected cephalosporins in drug formulations using flow injection analysis. J. Pharm. Biomed. Anal., 2001, 25(5-6), 751-757.
[22]
Shetty, S.K.; Yashwanth, R.; Manzoor, A.B. Development and validation of RP-HPLC method for quantitative estimation of cefoperazone in bulk and pharmaceutical dosage forms. Int. J. Chemtech Res., 2011, 3, 1075-1080.
[23]
Narasimha, L.; Basayya, P.S.; Pai, S.P.N. A stability-indicating HPLC method for cefoperazone. Eur. J. Anal. Chem, 2009, 4(1), 110-118.
[24]
Li, F.S.; Xu, Z.; Xiao, H.B.; Liang, X.M. Simultaneous determination of sulbactam sodium and cefoperazone sodium in sulperazone by high-performance liquid chromatography. Se Pu, 2000, 18(6), 525-526.
[25]
Kumar, V.; Dharuman, S.K. RP-HPLC method development and validation for simultaneous estimation of Sulbactam and Cefoperazone in dosage form and in plasma. Int. J. Pharma Bio Sci., 2010, 1(14), 87-92.
[26]
Tsou, T.L.; Huang, Y.C.; Lee, C.W.; Lee, A.R.; Wang, H.J.; Chen, S.H. Simultaneous determination of ampicillin, Cefoperazone and Sulbactam in pharmaceutical formulations by HPLC with β-cyclo dextrin stationary phase. J. Sep. Sci., 2007, 30(15), 2407-2413.
[27]
Sanjay, S.M.; Saira, M. Validated HPTLC Method for simultaneous determination of Cefoperazone sodium and Sulbactam sodium in combined dosage form. IOSR J. Pharm. Bio.Sci., 2014, 9(1), 21-25.
[28]
Laxman, M.P.; Anjali, P.; Jimish, R.P.; Amit, K.J.; Kharodiya, M. HPTLC method for simultaneous estimation of cefepime hydrochloride and Sulbactam sodium. Asian J. Pharm. Anal, 2016, 6(4), 207-212.
[29]
Zhou, Y.; Zhang, J.; Guo, B.; Yu, J.; Shi, Y.; Wang, M. Liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of Cefoperazone and Sulbactam in plasma and its application to a pharmacokinetic study. J. Chromato B., 2010, 848(30), 3119-3214.
[30]
Wang, R.H.; Cheng, L.M.; Qu, H.Y.; Hao, G.T.; Liu, Z.Y.; Xia, H. Determination of cefoperazone and sulbactam by LC-MS/MS in plasma and ultrafiltrate of patients undergone continuous renal replacement therapy. J. Intl. Pharm. Res, 2015, 42(2), 199-205.
[31]
Wu, X.J.; Huang, X.; Shi, H.Y.; Chen, X.K.; Dong, Q.; Hao, G.X. Determination of cefoperazone and sulbactam in serum by HPLC-MS/MS: An adapted method for therapeutic drug monitoring in children. Biomed. Chromatogr., 2018, 32, 41-43.
[32]
Tsujikawa, K.; Kuwayama, K.; Miyaguchi, H.; Kanamori, T.; Iwata, Y.; Inoue, H.; Kishi, T. A fatal case of suspected anaphylaxis with Cefoperazone and Sulbactam: LC-MS analysis. J. Forensic Sci., 2008, 53, 226-231.
[33]
ICH Q8 (R2), Harmonised Tripartite Guideline, on Pharmaceutical development. Proceedings of the International Conference on Harmonization;, 2009.
[34]
ICH Q9, Harmonised Tripartite Guideline, on Quality Risk Management. Proceedings of the International Conference on Harmonization;, 2005.
[35]
ICH Q2 (R1), Harmonised Tripartite Guideline, on Validation of analytical procedure. Proceedings of the International Conference on Harmonization. Geneva;, 2005.
[36]
Guideline for Industry. Text on Validation of Analytical Procedures, United States, March, 1995.
[37]
Blessy, M.; Ruchi, D.P.; Prajesh, N.P.; Agarwal, Y.K. Development of forced degradation and stability indicating studies of drugs. J. Pharm. Anal., 2014, 4, 159-165.